Stellantis Pro One won’t invest in hydrogen-powered vans anymore. Production ends in France and Poland
"The hydrogen market is showing no development prospect at mid-term", states a press note. As a result, Stellantis will no longer launch its new range of hydrogen-powered Pro One vehicles this year. Serial production was scheduled to start this summer in Hordain, France (medium-sized vans) and Gliwice, Poland (large vans). Such decision won't affect employment at Stellantis' plants, stated the Group.
Stellantis Pro One has officially decided to halt production of hydrogen-powered vans in Europe. “The hydrogen market is showing no development prospect at mid-term”, states a press note. For this reason, the group’s hydrogen fuel cell technology development program has been discontinued. Indeed, in May 2024, Stellantis had officially declared the intention to build “100,000 hydrogen-powered vans by the end of the decade“.
As a result, Stellantis will no longer launch its new range of hydrogen-powered Pro One vehicles this year. Serial production was scheduled to start this summer in Hordain, France (medium-sized vans) and Gliwice, Poland (large vans). Only a few days ago, Stellantis communicated the intention to stop hydrogen-related projects in the UK.
Stellantis abandons hydrogen projects in the LCV segment
“In a context where the Company is mobilizing to respond to demanding CO2 regulations in Europe, Stellantis has decided to discontinue its hydrogen fuel cell technology development program,” explained Jean-Philippe Imparato, Chief Operating Officer for Enlarged Europe. “The hydrogen market remains a niche segment, with no prospects of mid-term economic sustainability. We must make clear and responsible choices to ensure our competitiveness and meet the expectations of our customers with our electric and hybrid passenger and light commercial vehicles offensive.”
According to the automotive giant, such decision won’t have any particular impact on employment at Stellantis’ plants, as “R&D activities related to hydrogen technology will be redirected to other projects“. However, Stellantis “has initiated discussions with the shareholders of JV Symbio to evaluate the current market consequences and to preserve the best interests of Symbio, in line with their respective obligations”.
